NEW YORK (GenomeWeb News) - Response Genetics today said it will work with the University of California, San Francisco, on a two-year research study aimed at developing a diagnostic test kit for pancreatic cancer.
Â
The company said the study will combine data from patient outcomes with genetic information from formalin-fixed paraffin-embedded samples of pancreatic tissue provided by UCSF.
Â
Response Genetics will cover the costs of the project, while Margaret Tempero, deputy director of the UCSF Comprehensive Cancer Center, will lead the investigation.
Â
"Diagnostics tests emerging from this collaboration would help physicians tailor treatment to the individual by using genetic information to identify patients who would most benefit from surgery or chemotherapy and radiation," Response Genetics President and CEO Kathleen Danenberg said in a statement.